- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 06-02-2026: Press Release
06-02-2026 | 11:31 am
06-02-2026 | 11:31 am
Alembic Pharma secured USFDA final approval for Carbidopa, Levodopa and Entacapone Tablets, a generic for Parkinson's disease. This expands its US product portfolio, offering new revenue streams.
No comments yet. Be the first to comment!